Primrose Therapeutics Company
Primrose Therapeutics is engaged in the development of treatments for polycystic kidney disease.
Industry:
PharmTech
Technology:
Data-driven Technologies
Last Funding Type:
Seed
Headquarters:
New York, New York, United States
Founded Date:
2010
Funding Status:
Seed
Total Funding:
$752.6K
Estimated Revenue:
Less than $1M
Employee Number:
1-10